Introduction

58
The dopamine (DA) system is of key interest both in normal brain function and in the 59 pathophysiology of neurological 1 , and psychiatric 2,3 disorders. Striatum is the brain 60 region with the highest concentration of dopamine receptors 4 and also the most studied 61 using positron emission tomography (PET). In recent years, quantification of dopamine 62 receptors in extrastriatal regions has received more interest 2, 5 . Specifically, striatal and 63 extrastriatal availability of the dopamine D2 receptor family has been of particular 64 interest in psychiatry research as drugs targeting D2/3 receptors (D2/3R) is an established 65 treatment of psychosis and mood disorders 6 . 66
67
The dopamine D2/3R radioligand [ 11 C]raclopride was developed in the 80's 7 and is one 68 of the most frequently used PET radioligands to date. Due to its relatively low affinity to 69 D2/3R (Kd = 1.3 nM) [ 11 C]raclopride has primarily been used to study receptor 70 availability in striatal regions. Extrastriatally, the concentration of D2/3R is up to two 71 orders of magnitude lower than in striatum 8 . To study regions with low levels of D2/3R, 72 high affinity radioligands have been developed, e.g. 
Material and Methods
107
Study design 108
Two independent datasets were used for the competition and the test-retest design. In 109 COMP eleven healthy male subjects All subjects were examined using a high-resolution research tomograph (HRRT; 168 Siemens Molecular Imaging, USA) with a maximum spatial resolution of ~2mm full-169 width-half-maximum 27 . Transmission scans were performed prior to each PET 170 measurement in order to correct for signal attenuation. 171
Brain radioactivity was measured continuously, in COMP for 63 minutes and in 172
TRT for 51 minutes. The radioactivity was reconstructed in consecutive time frames, in 173 COMP, four 15 s, four 30 s, six 1 min, six 3 min and six 6 min frames. In TRT the initial 174 frame sequence was identical to COMP whereas the number of 6 min frames at end of 175 data acquisition was reduced to four. 176 177 Quantitative analysis 178 PET images were corrected for head motion using a frame-to-first-minute realignment 179 procedure 28 . Using SPM5 (Wellcome Department of Cognitive Neurology, University 180
College, London, UK), the T1-weighted MR-images were co-registered to a summed 181 PET-image. To obtain regional time-activity curves, the ROIs were projected onto the 182 realigned dynamic PET-image. 183
From the time-activity curves, BPND was estimated using the simplified reference 185 tissue model (SRTM) 29 . Cerebellum, a region where specific binding has been considered 186 negligible 8 , was used as reference. The cerebellar cortex volume was first defined using 187 
Results
235
In the COMP dataset, two subjects were excluded before image analysis due to excessive 236 head movement during the baseline measurement. Excessive head movement was defined 237 as more than 3 mm displacement from the reference position in more than 10% of the 238 frames as seen in the realignment plot. In addition, PET acquisition data from the 239 quetiapine IR measurement for one subject was excluded due to a delay of the 240 examination of two hours beyond expected Tmax for the plasma concentration of the drug. 241
Nine subjects were included in the final analysis of baseline and quetiapine XR data. For 242 the quetiapine IR data eight subjects were analyzed. In the TRT dataset SRTM failed in 243 the anterior cingulate cortex in one individual producing a negative BPND value. This 244 value was excluded from further analysis. 245
246
Results from COMP are shown in Figure 2 . In extrastriatal regions a significant decrease 247 of BPND was seen only in thalamus and temporal cortex (TC) after treatment with XR as 248 well as IR formulations of quetiapine (Table 1) . In putamen the occupancy was 33±11% 249 and 51±4% (mean±SD) in the quetiapine XR and IR measurements respectively. 250
Occupancy was lower in extrastriatal regions: 10±14% and 20±17% in thalamus and 251 12±11% and 18±17% in TC (Table 1) thalamus reflect specific binding. Estimations of effect sizes need to be adjusted 278 accordingly. Assuming that 10% difference in the density of D2/3R in thalamus is 279 considered a relevant clinical finding in a cross-sectional study, the corresponding 280 apparent effect size would be ~0.8, requiring 25 subjects per group for 80% power. Our 281 results however indicate that the actual effect size would be ~0.3, translating into 175 282 subjects per group. Importantly, a non-significant finding in an extrastriatal region in a 283 is in line with our observations of lower occupancy in regions with lower densities of 306 D2/3R (see Figure S2 for an explanation on how VND-bias propagates to occupancy 307 values). The presence of a discrete difference in VND between target and reference will 308 not matter much in receptor rich regions (i.e. striatum) but will become a serious validity 309 issue in low-binding regions. If, for example, VND is 10% lower in the reference region 310 then the "true" BPND in the target region will be falsely increased with 0.1 and 10% 33 . In, 311 e.g., frontal cortex where we might have a "true" [ several previous occupancy studies of quetiapine at steady-state using high affinity 322 radioligands have shown similar or higher occupancy of D2/3R in cortex compared to 323 striatum 34, 35 and no study has, to our knowledge, shown lower occupancy. This makes i-324
iii unlikely explanations to our findings. 325
326
There are some limitations to this study. The standardized uptake value (SUV) in 327 cerebellum was lower in the examinations performed after pretreatment with quetiapine 328 compared to baseline (supplement, Figure S3 and Table S1 ). This may be explained by (i) 329 presence of specific [
11 C]raclopride binding to D2/3R in cerebellum; (ii) that quetiapine 330 displaces non-specific binding of raclopride, or (iii) that quetiapine decreases 331 [
11 C]raclopride brain uptake. (i) will result in an underestimation of occupancy equally in 332 low-and high binding regions and would thus not alter the conclusions of our results 33, 36 . 333
The same is true for (ii) given that the displacement of non-specific binding is equal in all 334
regions. Additionally, we observed that centrum semiovale ( Figure S1 ), a region 335 containing only white matter, showed similar decrease of SUV ( Figure S3 ) which lends 336 support to explanation (ii) and (iii). The explanation we find most probable, (iii), would 337 also likely not affect our results since the decrease of measured radioactivity would be 338 proportional in target and reference regions. 339
Regarding the test-retest dataset, a caveat that should be highlighted is the fact 340 that time between examinations was 20±5 days. 
